Search This Blog

Thursday, November 7, 2019

Atara Biotherapeutics EPS beats by $0.10

Atara Biotherapeutics (NASDAQ:ATRA): Q3 GAAP EPS of -$1.31 beats by $0.10.
Cash and cash equivalents of $94.43M
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)